# Labcyte

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/labcyte

- Industry: Biotechnology
- Headquarters: Sunnyvale, US
- Website: www.labcyte.com
- Total disclosed funding: $53M
- Latest round: Series D (Jan 8, 2013)
- Investors on record: 9

## About

Founded in 2000, Labcyte Inc. operates as a biotechnology tools company that manufactures and markets echo liquid handling systems.

## Funding rounds

- Series D, Jan 8, 2013, $5.3M — Abingworth, Alloy Ventures, Delphi Ventures, GE Capital, Equity, Tekla Capital Management, Cross Atlantic Partners
- Series C, Jul 25, 2005, $21M — Abingworth, Alloy Ventures, Delphi Ventures, Sprout Group, Tekla Capital Management, Cross Atlantic Partners, DBL Partners
- Series B, Jul 9, 2002, $22M — Abingworth, Sprout Group
- Series A, Nov 1, 2000, $5.1M — Alloy Ventures, Delphi Ventures, Palo Alto Investors

## Investors

- Alloy Ventures (https://capitalatlas.ai/funds/alloy-ventures) — Series A, Series C, Series D
- Delphi Ventures (https://capitalatlas.ai/funds/delphi-ventures) — Series A, Series C, Series D
- Palo Alto Investors (https://capitalatlas.ai/funds/palo-alto-investors) — Series A
- Abingworth (https://capitalatlas.ai/funds/abingworth) — Series B, Series C, Series D
- Sprout Group (https://capitalatlas.ai/funds/sprout-group) — Series B, Series C
- Tekla Capital Management (https://capitalatlas.ai/funds/tekla-capital-management) — Series C, Series D
- Cross Atlantic Partners (https://capitalatlas.ai/funds/cross-atlantic-partners) — Series C, Series D
- DBL Partners (https://capitalatlas.ai/funds/dbl-partners) — Series C
- GE Capital, Equity (https://capitalatlas.ai/funds/ge-capital-equity) — Series D